BackIHH Healthcare Berhad Overview

IHH Healthcare Berhad EBIT

Latest ebit for 5225.KL: $4.3B, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$960.08M
↓ 0.92% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$4.33B
↓ 0.02% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

IHH Healthcare Berhad (5225.KL) FAQ

The latest EBIT for 5225.KL is $4.3B as of June 2026. That compares with $4.3B in the prior-year period — up 0.0% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside IHH Healthcare Berhad's historical trend and sector peers before judging valuation or financial health.

Over the past year, 5225.KL's EBIT moved from $4.3B to $4.3B — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in IHH Healthcare Berhad's operating scale or balance-sheet position.

Against its sector companies, 5225.KL currently prints $4.3B for EBIT, while the sector average sits near $2.6T. That is roughly 99.8% below the sector mean. Large gaps often invite a closer look at IHH Healthcare Berhad's growth, margins, and balance sheet.

A EBIT figure of $4.3B for 5225.KL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting 5225.KL's EBIT ($4.3B), review year-over-year change from $4.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.